Today on Citywire Money
Ezines and Guides
Investment fact sheets & tools
- AA-rated Reynolds brands gold 'legalised Ponzi scheme'
- New India manager Lim wary amid Modi euphoria
- Government under fire over Scottish independence memo
- Osborne denies involvement in Co-op's Lloyds bid
- Astra drives FTSE higher as Pfizer waits in wings
- 5 top investment trust picks from wealth managers
- Wells Fargo backs clean energy to boom in China
- The Expert View: Standard Chartered, SSP and Clinigen
- Thursday Papers: Bank of England unanimity on rates crumbles
- Overnight Markets: S&P 500 nears record after Fed minutes reassure on rates
- Investing in Banks - is it pointless?
- DIY Invester looking for advice.
- Adding Lump Sum To Personnel Pension
- Advice for a Young Invester
- ITALY VILLA HOLIDAY SCAM AUG.2014
- Hedging large lump sum
- Short positions (net)
- STATE PENSION & SAVINGS CREDIT ETC
- water meters good or bad,plus up to date comments regarding water.
- Discrepancies between sources when researching stocks?
- Skill Transfer UK Visa Investment
- Problems accessing forum directly
- Watchdog warns investors over corporate bonds
- 'New' ISAs: tax-free savings get bigger and better
- How to read a fund fact sheet
- Top trusts for Russia and emerging Europe
- Know the Score: Citywire's World Cup betting tips
- DIY Income Investor: time to take some bond profits
- Three lessons the World Cup can teach investors
- Be honest stock pickers, can you beat the FTSE?
- Diary of a Dumb Investor: Marriage, I'm filing for divorce
- How bond funds got out of jail
Biotechnology shares have had a turbulent year. Geoffrey Hsu of the Biotech Growth investment trust argues valuations of the bigger stocks remain compelling.
What is Citywire Money?
We're the independent guide to your financial life. We sift through the noise and help you make the best decisions about what to do with your money.
Just want to tell you guys what a great site this is! It is so 'spot on'! Keep up the good work.
Lydia McQueen, Citywire Money reader